acquired
Stage
About
Advencis developed a modular, fully automated early-detection system for microorganisms aimed at industrial microbiology (food and pharmaceutical industries) and clinical markets. Its technology provided highly sensitive detection of microbes on agar plates and filter-based devices and the company was acquired by bioMérieux in 2014.
Explore Advencis's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.